Skip to main content
Clinical Trials/NCT06150495
NCT06150495
Active, not recruiting
Not Applicable

Glycemic Control and Retinal Microvascular Changes in Type 2 Diabetes Mellitus Patients Without Clinical Retinopathy

Seoul National University Hospital1 site in 1 country259 target enrollmentJanuary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetic Retinopathy
Sponsor
Seoul National University Hospital
Enrollment
259
Locations
1
Primary Endpoint
Retinal vessel density (VD, %)
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this prospective, observational study is to compare in the association of glycemic control and retinal microvascular changes in patients with type 2 diabetes mellitus (T2DM) without diabetic retinopathy (DR).

The main question it aims to answer are:

• Do degenerative changes in retinal microvasculature or nerves depend on glycemic control even before diabetic retinopathy is detected?

Participants will receive an annual routine comprehensive examination including ultra-widefield fundus photography, spectral domain optical coherence tomography (OCT), and swept-source optical coherence tomography angiography (OCTA).

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The study included 30-70-year-old patients with T2DM without known DR at baseline who underwent regular screening for DR at the department of ophthalmology.
  • Who underwent regular checkups for DR between January 2019 and August 2022 at Dongguk University Ilsan Hospital.
  • The controls included patients without DM who presented for regular ophthalmic examination.

Exclusion Criteria

  • patients with a history of retinal or choroidal diseases (i.e., age-related macular degeneration, retinal vein occlusion, uveitis, retinal detachment, and central serous chorioretinopathy), glaucoma, or optic neuropathy
  • patients with neurodegenerative diseases, such as Parkinson's disease and dementia.

Outcomes

Primary Outcomes

Retinal vessel density (VD, %)

Time Frame: Upon initial registration and through study completion, an average of 1 year

The VD (%) was calculated using the following formula: VD (%) = vascular area (pixel) / (total area - FAZ area) (pixel) × 100.

The foveal avascular zone (FAZ) area (mm^2)

Time Frame: Upon initial registration and through study completion, an average of 1 year

FAZ was defined as the avascular area in the foveal center.

central foveal retinal thickness (um) and macular ganglion cell-inner plexiform layer (GC-IPL) thickness (um)

Time Frame: Upon initial registration and through study completion, an average of 1 year

Retinal layer thickness were calculated automatically using the bundled software

Study Sites (1)

Loading locations...

Similar Trials